PRAPEXOLE 0.25 TABLET

Product Description

PRAPEXOLE 0.25 TABLET is a premium-grade formulation of Pramipexol 0.25 mg, a dopamine agonist widely used in the treatment of Parkinsons disease and Restless Legs Syndrome (RLS). Engineered with precision and manufactured under WHO-GMP compliant facilities, this film-coated tablet ensures optimal bioavailability, patient tolerability, and long-term therapeutic benefits.

This product is ideal for pharma distributors, retail pharmacy chains, hospital procurement departments, and bulk pharmaceutical buyers looking to expand their neurology and movement disorder portfolios.

Key Benefits:

• Contains Pramipexol 0.25 mg, clinically proven for managing motor symptoms in Parkinsons

• Effective in reducing tremors, stiffness, and improving mobility

• Offers symptom relief in Restless Legs Syndrome (RLS)

• Manufactured under stringent quality standards for purity and consistency

Applications:

• Treatment of early and advanced Parkinsons disease

• Management of moderate to severe RLS

• Commonly prescribed in neurology and geriatric care settings

Why Choose PRAPEXOLE 0.25 TABLET?

• Trusted dopamine agonist for long-term symptom control

• Stable formulation with high patient adherence

• Available for bulk purchase, third-party manufacturing, and private labelling

• Competitive pricing for distributors and wholesale buyers